- Location
AMRI
"-
AMRI to Expand Container Closure Integrity Testing Services Into European Union
Feb 24, 2018AMRI, a global contract research, development and manufacturing organization working with the life sciences industry, is expanding leading container closure integrity testing (CCIT) services into the European Union. The company will build ...
Tags: life sciences industry, CCIT
-
AMRI,Chai Therapeutics Have Signed a Licensing Deal Developing Tubulin Inhibitor Compound
Feb 18, 2013Albany Molecular Research (AMRI) and Chai Therapeutics, an affiliate of Bessor Pharma, have signed a licensing deal to develop tubulin inhibitor compound, ALB 109564(a), for cancer treatment. AMRI's ALB 109564(a) is a novel analog ...
-
AMRI Will Continue to Supply an Aminobisamide Hydrochloride (ABA)
Dec 10, 2012AMRI will continue to supply an Aminobisamide Hydrochloride (ABA), an intermediate material used in diagnostic imaging agents, to GE Healthcare, under the signed long term supply agreement which extends till 31 December 2016. Under the ...
-
AMRI Has Reported a Net Loss of $2.14m for The Third Quarter
Nov 28, 2012Albany Molecular Research (AMRI) has reported a net loss of $2.14m, or $0.07 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.85m, or $0.19 per share, for the third quarter ended 30 September 2011. ...
-
Cardium Chooses Amri Us Site to Manufacture Pre-Filled Syringes
Nov 27, 2012Cardium Therapeutics and its Tissue Repair Company, Cardium, will utilize AMRI's Burlington, US, site to manufacture sterile pre-filled syringes in support of the US introduction of Excellagen, as per the signed contract agreement. ...
Tags: Cardium Therapeutics, syringe-based, pre-filled syringes
